FREDERIC H MOLL
CIK 1260157 · Executive Chairman · last filed 2026-06-10
FREDERIC H MOLL is an Executive Chairman who has filed 94 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for PRCT, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$4.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $58.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$58.52M
7
94
-$4.74M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRCT | Director | 866,474 | $17.79 | $15.41M | $7.72M | 9 | 2026-06-10 |
| SSII | Director | 10,775,485 | $4.00 | $43.10M | $2.00M | 1 | 2026-03-10 |
| Shockwave Medical, Inc. (SWAV) Delisted | Director | 33,960 | $334.75 | $11.37M | -$15.92M | 11 | 2024-05-31 |
| Intersect ENT, Inc. (XENT) Delisted | Director | 260,961 | $28.24 | $7.37M | -$947.9K | 23 | 2021-02-05 |
| Venus Concept Inc. (HAIR) Delisted | Director | 13,825 | — | — | $500.0K | 5 | 2019-11-07 |
| BIOLASE, INC (BIOL) Delisted | Director | 20 | $0.02 | $0 | $0 | 9 | 2017-07-03 |
| HANSEN MEDICAL INC (HNSN) Delisted | Executive Chairman | 279,008 | — | — | $1.91M | 14 | 2012-03-05 |
Recent Filings
94 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | PRCT | Grant (A) | +3,315 | $0 | EDGAR |
| 2026-03-10 | SSII | Buy (P) | +501,253 | $2.00M | EDGAR |
| 2025-08-14 | PRCT | Buy (P) | +20,000 | $785.1K | EDGAR |
| 2025-06-12 | PRCT | Grant (A) | +1,538 | $0 | EDGAR |
| 2025-02-24 | — | Buy (P) | +3,645,224 | $5.00M | |
| 2025-02-12 | PRCT | Exer (M) | +32,012 | $40.1K | EDGAR |
| 2025-01-10 | — | Buy (P) | +1,457,726 | $2.00M | |
| 2025-01-03 | — | Buy (P) | +2,186,589 | $3.00M | |
| 2024-11-27 | — | Buy (P) | +3,644,315 | $5.00M | |
| 2024-06-06 | PRCT | Grant (A) | +1,376 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.